|
JPS56158707A
(en)
*
|
1980-04-08 |
1981-12-07 |
Lion Corp |
Composition for oral use
|
|
JP3496158B2
(ja)
|
1993-01-26 |
2004-02-09 |
東洋カプセル株式会社 |
トラネキサム酸配合ゼラチンカプセル製剤
|
|
US5578568A
(en)
|
1994-04-22 |
1996-11-26 |
Xoma Corporation |
Method of treating conditions associated with intestinal ischemia/reperfusion
|
|
DE19617369A1
(de)
|
1996-04-30 |
1997-11-06 |
Immuno Ag |
Lagerstabile Fibrinogen-Präparate
|
|
JP3940209B2
(ja)
|
1996-11-14 |
2007-07-04 |
株式会社資生堂 |
可溶化化粧料
|
|
US6121232A
(en)
|
1997-01-31 |
2000-09-19 |
Omrix Biopharmaceuticals Sa |
Stabilized mixture comprising fibrinogen
|
|
WO1999008514A1
(en)
|
1997-08-20 |
1999-02-25 |
Lxr Biotechnology, Inc. |
Compositions containing polyethylene glycol and uses thereof
|
|
TWI243687B
(en)
|
1998-04-21 |
2005-11-21 |
Teijin Ltd |
Pharmaceutical composition for application to mucosa
|
|
DE10025001A1
(de)
|
2000-05-22 |
2001-11-29 |
Aventis Behring Gmbh |
Gewebekleber mit verbesserten anti-adhäsiven Eigenschaften
|
|
US7276235B2
(en)
|
1998-11-18 |
2007-10-02 |
Zlb Behring Gmbh |
Tissue glue with improved antiadhesive properties
|
|
US6534283B1
(en)
|
1999-11-24 |
2003-03-18 |
The Regents Of The University Of California |
Method for treatment and prevention of physiological shock
|
|
US6708822B1
(en)
|
1999-11-30 |
2004-03-23 |
Cutispharma, Inc. |
Compositions and kits for compounding pharmaceuticals
|
|
US20030144212A1
(en)
|
2000-07-06 |
2003-07-31 |
Hoffman Keith B |
Use of serine protease inhibitors to inhibit pathophysiology and neuropathology in a host
|
|
JP4044748B2
(ja)
|
2001-10-17 |
2008-02-06 |
サンスター株式会社 |
口腔用液体組成物
|
|
US20040018984A1
(en)
|
2002-07-17 |
2004-01-29 |
Mizuo Miyazaki |
Methods for preventing adhesion formation using protease inhibitors
|
|
GB0224909D0
(en)
|
2002-10-25 |
2002-12-04 |
Norgine Europe Bv |
Colon cleansing compositions
|
|
BR0215954A
(pt)
|
2002-11-26 |
2005-09-13 |
Uc Tech |
Métodos de redução da possibilidade de mortalidade em um animal, de expressão virulenta em um patógeno intestinal, e da expressão de adesina / lectina pa-i em uma célula bacteriana, de inibição de expressão de adesina / lectina pa-i em um patógeno intestinal, de ativação induzida por intestino de adesina / lectina pa-i, de mudança morfológica induzida por c4-hsl de um patógeno intestinal, e de aderência de célula bacteriana em um intestino de mamìfero, de melhoria de patogênese intestinal, de prevenção de uma doença ou condição anormal, de infecção de pele e respiratória, de uma doença sexualmente transmitida, de um distúrbio de trato digestivo, de perda de capacidade lactante em um animal, e de desenvolvimento de um distúrbio epitelial mediado por micróbio em uma animal de idade de amamentação, de irrigação de pelo menos uma porção do trato urinário, e para monitoração da administração de poli (etileno-glicol) (peg) a um animal, composição farmacêutica, kits para a prevenção ou tratamento terapêutico de sepsia derivada de intestino, e para a monitoração da administração de poli (etileno-glicol), e, preservativo
|
|
US20050025825A1
(en)
|
2003-07-31 |
2005-02-03 |
Xanodyne Pharmacal, Inc. |
Tranexamic acid formulations with reduced adverse effects
|
|
JP2005068076A
(ja)
|
2003-08-25 |
2005-03-17 |
Tendou Seiyaku Kk |
トラネキサム酸類を含む外用液剤および清拭剤
|
|
US20090215898A1
(en)
|
2004-03-04 |
2009-08-27 |
Xanodyne Pharmaceuticals, Inc. |
Tranexamic acid formulations
|
|
EP1744767A4
(en)
|
2004-04-20 |
2008-08-13 |
Univ Chicago |
THERAPEUTIC DELIVERY SYSTEM WITH PEG-LIKE CONNECTION WITH HIGH MOLECULAR WEIGHT
|
|
WO2007053194A2
(en)
|
2005-06-03 |
2007-05-10 |
The University Of Chicago |
Modulation of cell barrier dysfunction
|
|
AU2006255274A1
(en)
|
2005-06-03 |
2006-12-14 |
The University Of Chicago |
Modulation of microbial pathogen-host cell interactions
|
|
US20080194611A1
(en)
|
2005-06-03 |
2008-08-14 |
Alverdy John C |
Modulation of Cell Barrier Dysfunction
|
|
US20090186949A1
(en)
|
2006-02-28 |
2009-07-23 |
The University Of Chicago |
Method for Treating Endothelial and Epithelial Cell Disorders by Administering High Molecular Weight PEG-Like Compounds
|
|
JP5465824B2
(ja)
|
2006-03-24 |
2014-04-09 |
第一三共ヘルスケア株式会社 |
医薬用製剤およびその製造方法
|
|
US20100179091A1
(en)
|
2007-02-20 |
2010-07-15 |
The Regents Of The University Of California |
Treatment of Conditions Related to Shock
|
|
JP5093841B2
(ja)
|
2007-07-12 |
2012-12-12 |
株式会社 資生堂 |
不織布含浸化粧料
|
|
US9272034B2
(en)
|
2007-10-04 |
2016-03-01 |
The Regents Of The University Of California |
Treatment of conditions related to shock
|
|
US20100226995A1
(en)
|
2007-11-12 |
2010-09-09 |
Debrouse Daniel R |
Microencapsulated bioactive agents for oral delivery and methods of use thereof
|
|
WO2010087874A1
(en)
|
2009-01-28 |
2010-08-05 |
Anazyme, Llc |
Compositions and methods for diagnosis of shock
|
|
WO2009132149A2
(en)
|
2008-04-22 |
2009-10-29 |
The Regents Of The University Of California |
Treatment of conditions related to cecal ligation shock
|
|
AU2009244190B2
(en)
|
2008-05-07 |
2016-02-25 |
Salix Pharmaceuticals, Ltd. |
Methods of treating bowel disease by administering a bowel cleanser and an antibiotic
|
|
US7635707B1
(en)
*
|
2008-11-10 |
2009-12-22 |
Intermune, Inc. |
Pirfenidone treatment for patients with atypical liver function
|
|
JP5750096B2
(ja)
|
2009-03-23 |
2015-07-15 |
ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ |
放射線照射誘発型上皮障害を予防および治療する方法
|
|
CN102811762B
(zh)
*
|
2009-08-12 |
2014-08-27 |
皇家飞利浦电子股份有限公司 |
用于药物输送装置的药物容器
|
|
US20110060040A1
(en)
|
2009-09-04 |
2011-03-10 |
Xenoport, Inc. |
Uses of acyloxyalkyl carbamate prodrugs of tranexamic acid
|
|
CN102834104A
(zh)
|
2010-02-22 |
2012-12-19 |
优势医疗公司 |
治疗脑的出血性病状的方法和组合物
|
|
ES2951828T3
(es)
|
2010-09-23 |
2023-10-25 |
Leading Biosciences Inc |
Administración de inhibidores de serina proteasa al estómago
|
|
EP2621521A4
(en)
|
2010-10-02 |
2014-04-23 |
Univ California |
MINIMIZING DARMDYS FUNCTIONS
|
|
CN103099800B
(zh)
*
|
2011-11-11 |
2017-08-04 |
日本乐敦制药株式会社 |
含有氨甲环酸的外用和内服用组合物
|
|
ES2375784B1
(es)
|
2011-12-22 |
2013-01-24 |
Laboratorios Kin S.A. |
Gel de ácido tranexámico
|
|
CN103565743B
(zh)
|
2012-07-23 |
2016-06-22 |
上海市徐汇区中心医院 |
氨甲环酸皮肤外用纳米制剂及其制备方法和用途
|
|
WO2014028052A1
(en)
|
2012-08-17 |
2014-02-20 |
The University Of Chicago |
Materials and methods for preventing and treating anastomotic leaks
|
|
CN103054861A
(zh)
*
|
2012-12-29 |
2013-04-24 |
北京阜康仁生物制药科技有限公司 |
一种含氨甲环酸的复方固体制剂
|
|
US20140271923A1
(en)
|
2013-03-14 |
2014-09-18 |
Christopher Brian Reid |
Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
|
|
WO2015148474A1
(en)
|
2014-03-25 |
2015-10-01 |
Leading BioSciences, Inc. |
Compositions for the treatment of autodigestion
|
|
US20150297619A1
(en)
|
2014-04-17 |
2015-10-22 |
The Regents Of The University Of California |
Methods and compositions for preserving the mucosal barrier
|